The National Agency for Food and Drug Administration and Control (NAFDAC) has ordered the immediate removal, suspension, and cancellation of 101 products from circulation in Nigeria. The regulatory move was announced in an official statement released on Tuesday, marking a significant action to uphold public health and safety standards.
According to the agency, the affected products are now banned from manufacturing, importation, exportation, distribution, advertisement, sale, and use across Nigeria.
“These products are therefore no longer permitted for manufacture, importation, exportation, distribution, advertisement, sale and use within Nigeria,” NAFDAC said.
Why the Products Were Removed
NAFDAC explained that the regulatory action falls under three distinct categories:
- Withdrawal: This occurs when the Certificate of Registration is discontinued at the request of the Market Authorisation Holder.
- Suspension: This happens when the conditions under which the product was initially registered are no longer met.
- Cancellation: A complete revocation of the Certificate of Registration by NAFDAC.
“The Certificate of Registration of a product is said to be cancelled when the NAFDAC Certificate of Registration license of that product is revoked by NAFDAC,” the agency clarified.
Full List of Banned Products
The 101 affected products include various pharmaceuticals, herbal medicines, dietary supplements, and cosmetics. Some were voluntarily withdrawn by manufacturers, while others were forcefully cancelled due to non-compliance or safety concerns.
A few notable examples include:
- Abacavir Sulfate / Lamivudine Dispersible Tablets 60 mg/30 mg
- Amaryl M Tablets
- Uptivite Man
- Gentlehill Cough Syrup
- Betopic Eye Drop
What Consumers and Businesses Should Do
NAFDAC urges consumers to stop using any of the listed products immediately. Retailers, importers, and distributors are also warned to cease all commercial activity related to these items.
The agency said it will be conducting market surveillance and enforcement actions, including possible sanctions on non-compliant entities.
